{"name": "Telormedix",
 "permalink": "telormedix",
 "crunchbase_url": "http://www.crunchbase.com/company/telormedix",
 "homepage_url": "http://www.telormedix.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": null,
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "telormedix@telormedix.com",
 "phone_number": "41-(0)91-610-7000",
 "description": "",
 "created_at": "Wed Jan 11 04:06:41 UTC 2012",
 "updated_at": "Wed Feb 29 06:30:01 UTC 2012",
 "overview": "\u003Cp\u003ETelormedix is a biopharmaceutical company focused on targeted immunity and the role of the innate immune system in treating cancer and autoimmune diseases. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       58],
      "assets/images/resized/0016/9590/169590v1-max-150x150.jpg"],
     [[206,
       80],
      "assets/images/resized/0016/9590/169590v1-max-250x250.jpg"],
     [[206,
       80],
      "assets/images/resized/0016/9590/169590v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$8.3M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://onbiovc.com/telormedix-sa-series-b-83m/",
    "source_description": "Telormedix, SA.: Series B $8.3M",
    "raised_amount": 8300000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 2,
    "funded_day": 28,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Aravis Ventures",
         "permalink": "aravis-ventures",
         "image":
          {"available_sizes":
            [[[150,
               27],
              "assets/images/resized/0004/8028/48028v2-max-150x150.png"],
             [[208,
               38],
              "assets/images/resized/0004/8028/48028v2-max-250x250.png"],
             [[208,
               38],
              "assets/images/resized/0004/8028/48028v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "ProQuest Investments",
         "permalink": "proquest-investments",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0005/2876/52876v1-max-150x150.jpg"],
             [[236,
               79],
              "assets/images/resized/0005/2876/52876v1-max-250x250.jpg"],
             [[236,
               79],
              "assets/images/resized/0005/2876/52876v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Via della Posta 10",
    "address2": "",
    "zip_code": "CH-6934",
    "city": "Bioggio",
    "state_code": null,
    "country_code": "CHE",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        103],
       "assets/images/resized/0016/9591/169591v1-max-150x150.jpg"],
      [[250,
        172],
       "assets/images/resized/0016/9591/169591v1-max-250x250.jpg"],
      [[450,
        311],
       "assets/images/resized/0016/9591/169591v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}